SMS Pharmaceuticals Ltd — Capital/Financing Update 2024

Feb 5, 2024

==> picture [241 x 158] intentionally omitted <==

Date: 05[th] February, 2024

To, The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051.

Security Code: 532815 Symbol: SMSPHARMA

Dear Sir/Madam,

Sub: Prior Intimation of Notice of Board Meeting Pursuant Regulation 29(1)(d) of SEBI (LODR) Regulations, 2015.

Please refer to our earlier letter dated 02[nd] February, 2024 regarding the intimation of notice of Board Meeting of the Company scheduled to be held on Thursday, 08[th] February, 2024 to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the third quarter ended on 31st December, 2023.

In continuation of above, we wish to inform you that at the scheduled meeting to be held on 08[th] February, 2024 the Board of Directors of the Company inter-alia shall also consider the proposal for fund raising by way of issue of equity shares/ warrants and/or any other instruments/ securities on preferential basis to the promoters/promoter group, as may be permitted under applicable laws, subject to such regulatory or statutory approvals as may be required and the approval of the shareholders of the Company.

We request you to kindly take on record the same.

Thanking you Yours faithfully

For SMS Pharmaceuticals Limited

THIRUMALESH Digitally signed by THIRUMALESH TUMMA TUMMA Date: 2024.02.05 14:58:17 +05'30' Thirumalesh Tumma Company Secretary & Compliance Officer